{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:55:45Z","timestamp":1791608145950,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ophtha.2010.11.020","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T22:52:18Z","timestamp":1301352738000},"page":"1364-1372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["SCORE Study Report #11"],"prefix":"10.1016","volume":"118","author":[{"given":"Clement K.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"VanVeldhuisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal L.","family":"Oden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid U.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Tolentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Blodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2010.11.020_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9394(84)90316-7","article-title":"Argon laser photocoagulation for macular edema in branch vein occlusion","volume":"98","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archopht.1996.01100140443012","article-title":"Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study","volume":"114","author":"Mitchell","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archopht.126.4.513","article-title":"The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study","volume":"126","author":"Klein","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ajo.2006.06.015","article-title":"Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study","volume":"142","author":"Klein","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ophtha.2008.10.017","article-title":"SCORE Study report 1: Baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion","volume":"116","author":"Scott","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.11.020_bib6","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","volume":"127","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib7","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archophthalmol.2009.233","volume":"127","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archopht.123.4.581","article-title":"It's time for a clinical trial to investigate intravitreal triamcinolone for macular edema due to retinal vein occlusion: the SCORE Study [letter]","volume":"123","author":"Scott","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bjo.86.2.247","article-title":"Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion [letter]","volume":"86","author":"Greenberg","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib10","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archopht.122.8.1131","article-title":"Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion","volume":"122","author":"Ip","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00006982-200510000-00006","article-title":"Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion","volume":"25","author":"Cekic","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2010.11.020_bib12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1034\/j.1600-0420.2003.00176.x","article-title":"Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion","volume":"81","author":"Degenring","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2010.11.020_bib13","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/archopht.122.12.1801","article-title":"Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone","volume":"122","author":"Brooks","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1172\/JCI22869","article-title":"SDF-1 is both necessary and sufficient to promote proliferative retinopathy","volume":"115","author":"Butler","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ophtha.2010.11.020_bib15","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1096\/fj.06-7359com","article-title":"The SDF-1\/CXCR4 ligand\/receptor pair is an important contributor to several types of ocular neovascularization","volume":"21","author":"Lima e Silva","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.ophtha.2010.11.020_bib16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ophtha.2008.12.024","article-title":"Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy","volume":"116","author":"Arimura","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.11.020_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm0602-607","article-title":"Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization","volume":"8","author":"Grant","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.ophtha.2010.11.020_bib18","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/sj.leu.2404357","article-title":"The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.ophtha.2010.11.020_bib19","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/02713680701758727","article-title":"Stromal-derived factor-1 and inflammatory cytokines in retinal vein occlusion","volume":"32","author":"Ki-I","year":"2007","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2010.11.020_bib20","doi-asserted-by":"crossref","first-page":"13289","DOI":"10.1016\/S0021-9258(17)36831-X","article-title":"Novel mechanism of glucocorticoid-mediated gene repression: nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression","volume":"269","author":"Mukaida","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ophtha.2010.11.020_bib21","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1074\/jbc.M410616200","article-title":"Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists","volume":"280","author":"Nie","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ophtha.2010.11.020_bib22","series-title":"Manual of Policies and Procedures (MOPP) for the Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study, Version 4.0","year":"2008"},{"key":"10.1016\/j.ophtha.2010.11.020_bib23","series-title":"Protocol for the Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study, Version 7.0","year":"2008"},{"key":"10.1016\/j.ophtha.2010.11.020_bib24","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archophthalmol.2010.193","article-title":"Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study report 9","volume":"128","author":"Blodi","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0161-6420(13)38013-0","article-title":"Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.11.020_bib26","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.ophtha.2009.03.022","article-title":"SCORE Study report 3: study design and baseline characteristics","volume":"116","author":"Ip","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.11.020_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archopht.1986.01050130044017","article-title":"Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion: a randomized clinical trial","volume":"104","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archopht.1997.01100150488006","article-title":"Natural history and clinical management of central retinal vein occlusion","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.11.020_bib29","first-page":"OP166","article-title":"The natural course of retinal branch vein obstruction","volume":"78","author":"Michels","year":"1974","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642010012601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642010012601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:01:44Z","timestamp":1758981704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642010012601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0161642010012601"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2010.11.020","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SCORE Study Report #11","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2010.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}